The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study

OBJECTIVES: Evidence supports tocilizumab (TCZ) benefit and safety in adult patients with severe COVID-19. However, its effectiveness in critically ill older adult patients remains questionable. Thus, the study aimed to evaluate the safety and effectiveness of TCZ in older critically ill patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Korayem, Ghazwa B., Aljuhani, Ohoud, Altebainawi, Ali F., Shaya, Abdulrahman I. Al, Alnajjar, Lina I., Alissa, Abdulrahman, Aldhaeefi, Mohammed, Kensara, Raed, Al Muqati, Hessa, Alhuwahmel, Abdulmohsen, Alhuthaili, Omar, Vishwakarma, Ramesh, Aldardeer, Namareq, Eljaaly, Khalid, Alharbi, Aisha, Harbi, Shmeylan Al, Katheri, Abdulmalik Al, Bekairy, Abdulkareem M. Al, Aljedai, Ahmed, Al Sulaiman, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121644/
https://www.ncbi.nlm.nih.gov/pubmed/35605948
http://dx.doi.org/10.1016/j.ijid.2022.05.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121644/
https://www.ncbi.nlm.nih.gov/pubmed/35605948
http://dx.doi.org/10.1016/j.ijid.2022.05.038

Ejemplares similares